Literature DB >> 22099390

SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study.

Daniel E Adkins, Amit N Khachane, Joseph L McClay, Karolina Aberg, Jozsef Bukszár, Patrick F Sullivan, Edwin J C G van den Oord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22099390      PMCID： PMC3515657          DOI： 10.1016/j.schres.2011.11.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  9 in total

Review 1.  Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.

Authors:  S Miyamoto; G E Duncan; C E Marx; J A Lieberman
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 2.  Analysing biological pathways in genome-wide association studies.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nat Rev Genet       Date:  2010-12       Impact factor: 53.242

3.  Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.

Authors:  Yewon Cheon; Jee-Young Park; Hiren R Modi; Hyung-Wook Kim; Ho-Joo Lee; Lisa Chang; Jagadeesh S Rao; Stanley I Rapoport
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

4.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

5.  The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia.

Authors:  Isabel Martínez-Gras; Beatriz G Pérez-Nievas; Borja García-Bueno; José L M Madrigal; Eva Andrés-Esteban; Roberto Rodríguez-Jiménez; Janet Hoenicka; Tomás Palomo; Gabriel Rubio; Juan C Leza
Journal:  Schizophr Res       Date:  2011-02-18       Impact factor: 4.939

6.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

7.  Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Authors:  J L McClay; D E Adkins; K Aberg; S Stroup; D O Perkins; V I Vladimirov; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2009-09-01       Impact factor: 15.992

8.  A systematic method for estimating individual responses to treatment with antipsychotics in CATIE.

Authors:  Edwin J C G van den Oord; Daniel E Adkins; Joseph McClay; Jeffrey Lieberman; Patrick F Sullivan
Journal:  Schizophr Res       Date:  2008-10-18       Impact factor: 4.939

9.  The Edinburgh human metabolic network reconstruction and its functional analysis.

Authors:  Hongwu Ma; Anatoly Sorokin; Alexander Mazein; Alex Selkov; Evgeni Selkov; Oleg Demin; Igor Goryanin
Journal:  Mol Syst Biol       Date:  2007-09-18       Impact factor: 11.429
  9 in total
  20 in total

1.  EW_dmGWAS: edge-weighted dense module search for genome-wide association studies and gene expression profiles.

Authors:  Quan Wang; Hui Yu; Zhongming Zhao; Peilin Jia
Journal:  Bioinformatics       Date:  2015-03-24       Impact factor: 6.937

Review 2.  Incorporating epigenetic mechanisms to advance fetal programming theories.

Authors:  Elisabeth Conradt; Daniel E Adkins; Sheila E Crowell; K Lee Raby; Lisa M Diamond; Bruce Ellis
Journal:  Dev Psychopathol       Date:  2018-08

3.  Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis.

Authors:  Zhipeng Zhang; Aihong Luo; Zhijun Zeng; Yikai Zhou; Wei Wu
Journal:  J Gastrointest Oncol       Date:  2021-08

4.  Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.

Authors:  Borja García-Bueno; Miquel Bioque; Karina S Mac-Dowell; M Fe Barcones; Monica Martínez-Cengotitabengoa; Laura Pina-Camacho; Roberto Rodríguez-Jiménez; Pilar A Sáiz; Carmen Castro; Amalia Lafuente; Javier Santabárbara; Ana González-Pinto; Mara Parellada; Gabriel Rubio; M Paz García-Portilla; Juan A Micó; Miguel Bernardo; Juan C Leza
Journal:  Schizophr Bull       Date:  2013-03-13       Impact factor: 9.306

Review 5.  Ziprasidone versus other atypical antipsychotics for schizophrenia.

Authors:  Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Sandra Schwarz; Paranthaman Seth S Bhoopathi; Werner Kissling; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

6.  Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study.

Authors:  Borja García-Bueno; Miquel Bioque; Karina S MacDowell; Javier Santabárbara; Mónica Martínez-Cengotitabengoa; Carmen Moreno; Pilar A Sáiz; Esther Berrocoso; Patricia Gassó; M Fe Barcones; Ana González-Pinto; Mara Parellada; Julio Bobes; Juan A Micó; Miguel Bernardo; Juan C Leza
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

7.  Inferring drug-disease associations based on known protein complexes.

Authors:  Liang Yu; Jianbin Huang; Zhixin Ma; Jing Zhang; Yapeng Zou; Lin Gao
Journal:  BMC Med Genomics       Date:  2015-05-29       Impact factor: 3.063

8.  Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress.

Authors:  K S MacDowell; J R Caso; D Martín-Hernández; J L Madrigal; J C Leza; B García-Bueno
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

9.  Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations.

Authors:  Ajay Jajodia; Harpreet Kaur; Kalpana Kumari; Neha Kanojia; Meenal Gupta; Ruchi Baghel; Mamta Sood; Sanjeev Jain; Rakesh K Chadda; Ritushree Kukreti
Journal:  Mol Genet Genomic Med       Date:  2015-08-09       Impact factor: 2.183

10.  Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*D.

Authors:  Daniel E Adkins; Renan P Souza; Karolina Aberg; Shaunna L Clark; Joseph L McClay; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.